Merus - Stock Price History | MRUS
Historical daily share price chart and data for Merus since 2021 adjusted for splits. The latest closing stock price for Merus as of September 24, 2021 is 22.21.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
- The all-time high Merus stock closing price was 32.23 on March 06, 2017.
- The Merus 52-week high stock price is 31.27, which is 40.8% above the current share price.
- The Merus 52-week low stock price is 11.19, which is 49.6% below the current share price.
- The average Merus stock price for the last 52 weeks is 20.19.
|Merus Historical Annual Stock Price Data
||Average Stock Price
||Annual % Change
||Medical - Biomedical and Genetics
Merus B.V. is a clinical-stage immuno-oncology company developing bispecific antibody therapeutics, referred to as Biclonics. The company's bispecific antibody candidate, MCLA-128, is being evaluated in a Phase 1/2 clinical trial as a potential treatment for HER2-expressing solid tumors; MCLA-117, is being developed as a potential treatment for acute myeloid leukemia and MCLA-158, which is designed to bind to cancer stem cells and is being developed as a potential treatment for colorectal cancer and other solid tumors. Merus B.V. is headquartered in Utrecht, the Netherlands.